Literature DB >> 10665462

Fluoxetine as an adjunct to conventional antipsychotic treatment of schizophrenia patients with residual symptoms.

C Arango1, B Kirkpatrick, R W Buchanan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10665462     DOI： 10.1097/00005053-200001000-00010

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN： 0022-3018            Impact factor:   2.254


× No keyword cloud information.
  7 in total

1.  Treatment of obsessive compulsive symptoms in schizophrenia with fluoxetine.

Authors:  V Agarwal; K M Agarwal
Journal:  Indian J Psychiatry       Date:  2000-07       Impact factor: 1.759

Review 2.  Antidepressants for people with both schizophrenia and depression.

Authors:  C Whitehead; S Moss; A Cardno; G Lewis
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 3.  Management of the negative symptoms of schizophrenia: new treatment options.

Authors:  Hans-Jürgen Möller
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

4.  Treatment-refractory schizophrenia.

Authors:  Asaf Caspi; Michael Davidson; Carol A Tamminga
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

Review 5.  Randomized Controlled Trials of Add-On Antidepressants in Schizophrenia.

Authors:  Viacheslav Terevnikov; Grigori Joffe; Jan-Henry Stenberg
Journal:  Int J Neuropsychopharmacol       Date:  2015-05-19       Impact factor: 5.176

Review 6.  Augmentation with antidepressants in schizophrenia treatment: benefit or risk.

Authors:  Ye-Meng Mao; Ming-Dao Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-16       Impact factor: 2.570

Review 7.  Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia.

Authors:  Qiongqiong Wu; Xiaoyi Wang; Ying Wang; Yu-Jun Long; Jing-Ping Zhao; Ren-Rong Wu
Journal:  Neurosci Bull       Date:  2021-07-05       Impact factor: 5.203
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.